UnitedHealth Group, Amedisys Deal Deadline Extended

UnitedHealth Group (NYSE: UNH) subsidiary Optum entered a new waiver agreement that has delayed the deadline to complete its $3.3 billion acquisition of Amedisys (Nasdaq: AMED). The agreement comes on the heels of an antitrust lawsuit that the U.S. Department of Justice (DOJ) filed last month to block the transaction due to concerns that it […]

Joining Forces: 2024’s Hospice Investment, Consolidation Trends

Hospice investment trends took myriad routes this year, seeing a few common threads occurring among nonprofit and for-profit entities that hint at where the market may be heading. The scope of hospice deals in 2024 encompassed joint ventures and collaborative affiliations in addition to acquisitions. Some of these transactions were fueled by value-based reimbursement and […]

Hospice Utilization Rebounds to Pre-Pandemic Levels, but Fraud Casts a Shadow

The nation’s hospice utilization rate among Medicare decedents has once again surpassed 50%, for the first time since the pandemic. However, fraud issues in the space create questions around the quality of care patients are receiving. Hospice utilization reached 51.7% in 2023, up more than two percentage points from the prior year, according to recent […]

New Day Healthcare Acquires Good Samaritan Society’s Hospice Operations

Texas-based New Day Healthcare LLC has announced its acquisition of Good Samaritan Society’s hospice operations in its home state. The financial terms of the deal were undisclosed.  The transaction includes Good Samaritan’s hospice assets in El Paso, Texas, expanding New Day’s existing presence in that market. The deal marks an important strategic move as New […]

The ISNP Opportunity for Hospice Providers

Hospice providers can collaborate with institutional special needs Medicare Advantage plans (ISNP) to reach patients who reside in long-term care facilities. ISNPs restrict enrollment to MA eligible individuals who, for 90 days or longer, have had or are expected to need the level of services provided in a long-term care (LTC), skilled nursing facility, a […]

Addus Closes $350M Gentiva Personal Care Deal

Addus HomeCare Corporation (Nasdaq: ADUS) has closed its $350 million acquisition of Gentiva’s personal care business. Gentiva’s personal care segment brings in annual revenues of close to $280.0 million. Post-transaction, Addus will continue with a leverage ratio of less than 3x, with the ability to further that amount with the influx of revenue resulting from […]

New Day Secures $125M Investment to Fuel Hospice, Home Health Growth

New Day Healthcare LLC recently secured a $125 million senior credit facility with First Citizens Bank. That capital access will support the company’s acquisition pipeline in home health, hospice and personal care. Part of the funds will be utilized to complete the acquisition of four facilities, as well as several other transactions under consideration, according […]

Addus Taking a Cautious Approach to Hospice Deals

Valuations in the hospice space have led Addus Homecare (Nasdaq: ADUS) to take a more conservative approach to hospice transactions as it actively seeks home health and personal care deals. Hospice multiples reach record highs in 2020 and 2021, as much as 26x. Since then the price tags have reportedly come down, but they haven’t […]

Hospice a Cornerstone of New Day’s 3-Pronged Growth Strategy

New Day Healthcare LLC is prioritizing hospice growth in its strategic plans as the home-based care company focuses on improving quality for patients across the care continuum. Texas-based New Day launched in 2020 by a group of former hospice and home health professionals. The organization offers hospice, home health and personal care through several brands. […]

Inside the Justice Department’s Amedisys-Optum Lawsuit

The rationale behind the U.S. Justice Department’s lawsuit against Optum and Amedisys (Nasdaq: AMED) is multi-faceted, citing potential adverse impacts on competition, home-based care workers and payers. Optum, a subsidiary of UnitedHealth Group (NYSE: UNH) in June 2023 penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]